Global Human Tetanus Immunoglobulin Market Insights and Forecast to 2026
- BMR3911210
- 119 Pages
- June 2020
- Healthcare
Prior to COVID-19, the market for Human Tetanus Immunoglobulin was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Human Tetanus Immunoglobulin is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Human Tetanus Immunoglobulin market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Human Tetanus Immunoglobulin market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Human Tetanus Immunoglobulin industry.
Global Human Tetanus Immunoglobulin Scope and Segment
Human Tetanus Immunoglobulin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Human Tetanus Immunoglobulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Baxalta
CSL
Octapharma
Grifols
LFB
Biotest
Kedrion
Hualan Biological Engineering
Human Tetanus Immunoglobulin Breakdown Data by Type
Injection
Freeze-dried Injection
Human Tetanus Immunoglobulin Breakdown Data by Application
Adults
Children
Regional and Country-level Analysis
The Human Tetanus Immunoglobulin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Human Tetanus Immunoglobulin market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Human Tetanus Immunoglobulin Market Share Analysis
1.1 Human Tetanus Immunoglobulin Product Introduction
1.2 Market Segments
1.3 Key Human Tetanus Immunoglobulin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Human Tetanus Immunoglobulin Market Size Growth Rate by Type
1.4.2 Injection
1.4.3 Freeze-dried Injection
1.5 Market by Application
1.5.1 Global Human Tetanus Immunoglobulin Market Size Growth Rate by Application
1.5.2 Adults
1.5.3 Children
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Human Tetanus Immunoglobulin Market Size, Estimates and Forecasts
2.1.1 Global Human Tetanus Immunoglobulin Revenue 2015-2026
2.1.2 Global Human Tetanus Immunoglobulin Sales 2015-2026
2.2 Global Human Tetanus Immunoglobulin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Human Tetanus Immunoglobulin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Human Tetanus Immunoglobulin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Human Tetanus Immunoglobulin Competitor Landscape by Players
3.1 Human Tetanus Immunoglobulin Sales by Manufacturers
3.1.1 Human Tetanus Immunoglobulin Sales by Manufacturers (2015-2020)
3.1.2 Human Tetanus Immunoglobulin Sales Market Share by Manufacturers (2015-2020)
3.2 Human Tetanus Immunoglobulin Revenue by Manufacturers
3.2.1 Human Tetanus Immunoglobulin Revenue by Manufacturers (2015-2020)
3.2.2 Human Tetanus Immunoglobulin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Tetanus Immunoglobulin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human Tetanus Immunoglobulin Revenue in 2019
3.2.5 Global Human Tetanus Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Human Tetanus Immunoglobulin Price by Manufacturers
3.4 Human Tetanus Immunoglobulin Manufacturing Base Distribution, Product Types
3.4.1 Human Tetanus Immunoglobulin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Tetanus Immunoglobulin Product Type
3.4.3 Date of International Manufacturers Enter into Human Tetanus Immunoglobulin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Human Tetanus Immunoglobulin Market Size by Type (2015-2020)
4.1.1 Global Human Tetanus Immunoglobulin Sales by Type (2015-2020)
4.1.2 Global Human Tetanus Immunoglobulin Revenue by Type (2015-2020)
4.1.3 Human Tetanus Immunoglobulin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Human Tetanus Immunoglobulin Market Size Forecast by Type (2021-2026)
4.2.1 Global Human Tetanus Immunoglobulin Sales Forecast by Type (2021-2026)
4.2.2 Global Human Tetanus Immunoglobulin Revenue Forecast by Type (2021-2026)
4.2.3 Human Tetanus Immunoglobulin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Human Tetanus Immunoglobulin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Human Tetanus Immunoglobulin Market Size by Application (2015-2020)
5.1.1 Global Human Tetanus Immunoglobulin Sales by Application (2015-2020)
5.1.2 Global Human Tetanus Immunoglobulin Revenue by Application (2015-2020)
5.1.3 Human Tetanus Immunoglobulin Price by Application (2015-2020)
5.2 Human Tetanus Immunoglobulin Market Size Forecast by Application (2021-2026)
5.2.1 Global Human Tetanus Immunoglobulin Sales Forecast by Application (2021-2026)
5.2.2 Global Human Tetanus Immunoglobulin Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Tetanus Immunoglobulin Price Forecast by Application (2021-2026)
6 North America
6.1 North America Human Tetanus Immunoglobulin by Country
6.1.1 North America Human Tetanus Immunoglobulin Sales by Country
6.1.2 North America Human Tetanus Immunoglobulin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Human Tetanus Immunoglobulin Market Facts & Figures by Type
6.3 North America Human Tetanus Immunoglobulin Market Facts & Figures by Application
7 Europe
7.1 Europe Human Tetanus Immunoglobulin by Country
7.1.1 Europe Human Tetanus Immunoglobulin Sales by Country
7.1.2 Europe Human Tetanus Immunoglobulin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Tetanus Immunoglobulin Market Facts & Figures by Type
7.3 Europe Human Tetanus Immunoglobulin Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Human Tetanus Immunoglobulin by Region
8.1.1 Asia Pacific Human Tetanus Immunoglobulin Sales by Region
8.1.2 Asia Pacific Human Tetanus Immunoglobulin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Human Tetanus Immunoglobulin Market Facts & Figures by Type
8.3 Asia Pacific Human Tetanus Immunoglobulin Market Facts & Figures by Application
9 Latin America
9.1 Latin America Human Tetanus Immunoglobulin by Country
9.1.1 Latin America Human Tetanus Immunoglobulin Sales by Country
9.1.2 Latin America Human Tetanus Immunoglobulin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Human Tetanus Immunoglobulin Market Facts & Figures by Type
9.3 Central & South America Human Tetanus Immunoglobulin Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Human Tetanus Immunoglobulin by Country
10.1.1 Middle East and Africa Human Tetanus Immunoglobulin Sales by Country
10.1.2 Middle East and Africa Human Tetanus Immunoglobulin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Human Tetanus Immunoglobulin Market Facts & Figures by Type
10.3 Middle East and Africa Human Tetanus Immunoglobulin Market Facts & Figures by Application
11 Company Profiles
11.1 Baxalta
11.1.1 Baxalta Corporation Information
11.1.2 Baxalta Description and Business Overview
11.1.3 Baxalta Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxalta Human Tetanus Immunoglobulin Products Offered
11.1.5 Baxalta Related Developments
11.2 CSL
11.2.1 CSL Corporation Information
11.2.2 CSL Description and Business Overview
11.2.3 CSL Sales, Revenue and Gross Margin (2015-2020)
11.2.4 CSL Human Tetanus Immunoglobulin Products Offered
11.2.5 CSL Related Developments
11.3 Octapharma
11.3.1 Octapharma Corporation Information
11.3.2 Octapharma Description and Business Overview
11.3.3 Octapharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Octapharma Human Tetanus Immunoglobulin Products Offered
11.3.5 Octapharma Related Developments
11.4 Grifols
11.4.1 Grifols Corporation Information
11.4.2 Grifols Description and Business Overview
11.4.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Grifols Human Tetanus Immunoglobulin Products Offered
11.4.5 Grifols Related Developments
11.5 LFB
11.5.1 LFB Corporation Information
11.5.2 LFB Description and Business Overview
11.5.3 LFB Sales, Revenue and Gross Margin (2015-2020)
11.5.4 LFB Human Tetanus Immunoglobulin Products Offered
11.5.5 LFB Related Developments
11.6 Biotest
11.6.1 Biotest Corporation Information
11.6.2 Biotest Description and Business Overview
11.6.3 Biotest Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Biotest Human Tetanus Immunoglobulin Products Offered
11.6.5 Biotest Related Developments
11.7 Kedrion
11.7.1 Kedrion Corporation Information
11.7.2 Kedrion Description and Business Overview
11.7.3 Kedrion Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Kedrion Human Tetanus Immunoglobulin Products Offered
11.7.5 Kedrion Related Developments
11.8 Hualan Biological Engineering
11.8.1 Hualan Biological Engineering Corporation Information
11.8.2 Hualan Biological Engineering Description and Business Overview
11.8.3 Hualan Biological Engineering Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Hualan Biological Engineering Human Tetanus Immunoglobulin Products Offered
11.8.5 Hualan Biological Engineering Related Developments
11.1 Baxalta
11.1.1 Baxalta Corporation Information
11.1.2 Baxalta Description and Business Overview
11.1.3 Baxalta Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxalta Human Tetanus Immunoglobulin Products Offered
11.1.5 Baxalta Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Human Tetanus Immunoglobulin Market Estimates and Projections by Region
12.1.1 Global Human Tetanus Immunoglobulin Sales Forecast by Regions 2021-2026
12.1.2 Global Human Tetanus Immunoglobulin Revenue Forecast by Regions 2021-2026
12.2 North America Human Tetanus Immunoglobulin Market Size Forecast (2021-2026)
12.2.1 North America: Human Tetanus Immunoglobulin Sales Forecast (2021-2026)
12.2.2 North America: Human Tetanus Immunoglobulin Revenue Forecast (2021-2026)
12.2.3 North America: Human Tetanus Immunoglobulin Market Size Forecast by Country (2021-2026)
12.3 Europe Human Tetanus Immunoglobulin Market Size Forecast (2021-2026)
12.3.1 Europe: Human Tetanus Immunoglobulin Sales Forecast (2021-2026)
12.3.2 Europe: Human Tetanus Immunoglobulin Revenue Forecast (2021-2026)
12.3.3 Europe: Human Tetanus Immunoglobulin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Human Tetanus Immunoglobulin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Human Tetanus Immunoglobulin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Human Tetanus Immunoglobulin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Human Tetanus Immunoglobulin Market Size Forecast by Region (2021-2026)
12.5 Latin America Human Tetanus Immunoglobulin Market Size Forecast (2021-2026)
12.5.1 Latin America: Human Tetanus Immunoglobulin Sales Forecast (2021-2026)
12.5.2 Latin America: Human Tetanus Immunoglobulin Revenue Forecast (2021-2026)
12.5.3 Latin America: Human Tetanus Immunoglobulin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Human Tetanus Immunoglobulin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Human Tetanus Immunoglobulin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Human Tetanus Immunoglobulin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Human Tetanus Immunoglobulin Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Human Tetanus Immunoglobulin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Tetanus Immunoglobulin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Human Tetanus Immunoglobulin Market Segments
Table 2. Ranking of Global Top Human Tetanus Immunoglobulin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Tetanus Immunoglobulin Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Injection
Table 5. Major Manufacturers of Freeze-dried Injection
Table 6. Global Human Tetanus Immunoglobulin Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 7. Global Human Tetanus Immunoglobulin Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 8. Global Human Tetanus Immunoglobulin Sales by Regions 2015-2020 (K Doses)
Table 9. Global Human Tetanus Immunoglobulin Sales Market Share by Regions (2015-2020)
Table 10. Global Human Tetanus Immunoglobulin Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Human Tetanus Immunoglobulin Sales by Manufacturers (2015-2020) (K Doses)
Table 12. Global Human Tetanus Immunoglobulin Sales Share by Manufacturers (2015-2020)
Table 13. Global Human Tetanus Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Human Tetanus Immunoglobulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Tetanus Immunoglobulin as of 2019)
Table 15. Human Tetanus Immunoglobulin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Human Tetanus Immunoglobulin Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Human Tetanus Immunoglobulin Price (2015-2020) (USD/Dose)
Table 18. Human Tetanus Immunoglobulin Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Human Tetanus Immunoglobulin Product Type
Table 20. Date of International Manufacturers Enter into Human Tetanus Immunoglobulin Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Human Tetanus Immunoglobulin Sales by Type (2015-2020) (K Doses)
Table 23. Global Human Tetanus Immunoglobulin Sales Share by Type (2015-2020)
Table 24. Global Human Tetanus Immunoglobulin Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Human Tetanus Immunoglobulin Revenue Share by Type (2015-2020)
Table 26. Human Tetanus Immunoglobulin Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 27. Global Human Tetanus Immunoglobulin Sales by Application (2015-2020) (K Doses)
Table 28. Global Human Tetanus Immunoglobulin Sales Share by Application (2015-2020)
Table 29. North America Human Tetanus Immunoglobulin Sales by Country (2015-2020) (K Doses)
Table 30. North America Human Tetanus Immunoglobulin Sales Market Share by Country (2015-2020)
Table 31. North America Human Tetanus Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Human Tetanus Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 33. North America Human Tetanus Immunoglobulin Sales by Type (2015-2020) (K Doses)
Table 34. North America Human Tetanus Immunoglobulin Sales Market Share by Type (2015-2020)
Table 35. North America Human Tetanus Immunoglobulin Sales by Application (2015-2020) (K Doses)
Table 36. North America Human Tetanus Immunoglobulin Sales Market Share by Application (2015-2020)
Table 37. Europe Human Tetanus Immunoglobulin Sales by Country (2015-2020) (K Doses)
Table 38. Europe Human Tetanus Immunoglobulin Sales Market Share by Country (2015-2020)
Table 39. Europe Human Tetanus Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Human Tetanus Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 41. Europe Human Tetanus Immunoglobulin Sales by Type (2015-2020) (K Doses)
Table 42. Europe Human Tetanus Immunoglobulin Sales Market Share by Type (2015-2020)
Table 43. Europe Human Tetanus Immunoglobulin Sales by Application (2015-2020) (K Doses)
Table 44. Europe Human Tetanus Immunoglobulin Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Human Tetanus Immunoglobulin Sales by Region (2015-2020) (K Doses)
Table 46. Asia Pacific Human Tetanus Immunoglobulin Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Human Tetanus Immunoglobulin Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Human Tetanus Immunoglobulin Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Human Tetanus Immunoglobulin Sales by Type (2015-2020) (K Doses)
Table 50. Asia Pacific Human Tetanus Immunoglobulin Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Human Tetanus Immunoglobulin Sales by Application (2015-2020) (K Doses)
Table 52. Asia Pacific Human Tetanus Immunoglobulin Sales Market Share by Application (2015-2020)
Table 53. Latin America Human Tetanus Immunoglobulin Sales by Country (2015-2020) (K Doses)
Table 54. Latin America Human Tetanus Immunoglobulin Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Human Tetanus Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Human Tetanus Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 57. Latin America Human Tetanus Immunoglobulin Sales by Type (2015-2020) (K Doses)
Table 58. Latin America Human Tetanus Immunoglobulin Sales Market Share by Type (2015-2020)
Table 59. Latin America Human Tetanus Immunoglobulin Sales by Application (2015-2020) (K Doses)
Table 60. Latin America Human Tetanus Immunoglobulin Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Human Tetanus Immunoglobulin Sales by Country (2015-2020) (K Doses)
Table 62. Middle East and Africa Human Tetanus Immunoglobulin Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Human Tetanus Immunoglobulin Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Human Tetanus Immunoglobulin Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Human Tetanus Immunoglobulin Sales by Type (2015-2020) (K Doses)
Table 66. Middle East and Africa Human Tetanus Immunoglobulin Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Human Tetanus Immunoglobulin Sales by Application (2015-2020) (K Doses)
Table 68. Middle East and Africa Human Tetanus Immunoglobulin Sales Market Share by Application (2015-2020)
Table 69. Baxalta Corporation Information
Table 70. Baxalta Description and Major Businesses
Table 71. Baxalta Human Tetanus Immunoglobulin Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 72. Baxalta Product
Table 73. Baxalta Recent Development
Table 74. CSL Corporation Information
Table 75. CSL Description and Major Businesses
Table 76. CSL Human Tetanus Immunoglobulin Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 77. CSL Product
Table 78. CSL Recent Development
Table 79. Octapharma Corporation Information
Table 80. Octapharma Description and Major Businesses
Table 81. Octapharma Human Tetanus Immunoglobulin Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 82. Octapharma Product
Table 83. Octapharma Recent Development
Table 84. Grifols Corporation Information
Table 85. Grifols Description and Major Businesses
Table 86. Grifols Human Tetanus Immunoglobulin Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 87. Grifols Product
Table 88. Grifols Recent Development
Table 89. LFB Corporation Information
Table 90. LFB Description and Major Businesses
Table 91. LFB Human Tetanus Immunoglobulin Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 92. LFB Product
Table 93. LFB Recent Development
Table 94. Biotest Corporation Information
Table 95. Biotest Description and Major Businesses
Table 96. Biotest Human Tetanus Immunoglobulin Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 97. Biotest Product
Table 98. Biotest Recent Development
Table 99. Kedrion Corporation Information
Table 100. Kedrion Description and Major Businesses
Table 101. Kedrion Human Tetanus Immunoglobulin Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 102. Kedrion Product
Table 103. Kedrion Recent Development
Table 104. Hualan Biological Engineering Corporation Information
Table 105. Hualan Biological Engineering Description and Major Businesses
Table 106. Hualan Biological Engineering Human Tetanus Immunoglobulin Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 107. Hualan Biological Engineering Product
Table 108. Hualan Biological Engineering Recent Development
Table 109. Global Human Tetanus Immunoglobulin Sales Forecast by Regions (2021-2026) (K Doses)
Table 110. Global Human Tetanus Immunoglobulin Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Human Tetanus Immunoglobulin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Human Tetanus Immunoglobulin Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Human Tetanus Immunoglobulin Sales Forecast by Country (2021-2026) (K Doses)
Table 114. North America: Human Tetanus Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Human Tetanus Immunoglobulin Sales Forecast by Country (2021-2026) (K Doses)
Table 116. Europe: Human Tetanus Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Human Tetanus Immunoglobulin Sales Forecast by Region (2021-2026) (K Doses)
Table 118. Asia Pacific: Human Tetanus Immunoglobulin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Human Tetanus Immunoglobulin Sales Forecast by Country (2021-2026) (K Doses)
Table 120. Latin America: Human Tetanus Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Human Tetanus Immunoglobulin Sales Forecast by Country (2021-2026) (K Doses)
Table 122. Middle East and Africa: Human Tetanus Immunoglobulin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Human Tetanus Immunoglobulin Players
Table 127. Human Tetanus Immunoglobulin Customers List
Table 128. Human Tetanus Immunoglobulin Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Tetanus Immunoglobulin Product Picture
Figure 2. Global Human Tetanus Immunoglobulin Sales Market Share by Type in 2020 & 2026
Figure 3. Injection Product Picture
Figure 4. Freeze-dried Injection Product Picture
Figure 5. Global Human Tetanus Immunoglobulin Sales Market Share by Application in 2020 & 2026
Figure 6. Adults
Figure 7. Children
Figure 8. Human Tetanus Immunoglobulin Report Years Considered
Figure 9. Global Human Tetanus Immunoglobulin Market Size 2015-2026 (US$ Million)
Figure 10. Global Human Tetanus Immunoglobulin Sales 2015-2026 (K Doses)
Figure 11. Global Human Tetanus Immunoglobulin Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Human Tetanus Immunoglobulin Sales Market Share by Region (2015-2020)
Figure 13. Global Human Tetanus Immunoglobulin Sales Market Share by Region in 2019
Figure 14. Global Human Tetanus Immunoglobulin Revenue Market Share by Region (2015-2020)
Figure 15. Global Human Tetanus Immunoglobulin Revenue Market Share by Region in 2019
Figure 16. Global Human Tetanus Immunoglobulin Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Human Tetanus Immunoglobulin Revenue in 2019
Figure 18. Human Tetanus Immunoglobulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Human Tetanus Immunoglobulin Sales Market Share by Type (2015-2020)
Figure 20. Global Human Tetanus Immunoglobulin Sales Market Share by Type in 2019
Figure 21. Global Human Tetanus Immunoglobulin Revenue Market Share by Type (2015-2020)
Figure 22. Global Human Tetanus Immunoglobulin Revenue Market Share by Type in 2019
Figure 23. Global Human Tetanus Immunoglobulin Market Share by Price Range (2015-2020)
Figure 24. Global Human Tetanus Immunoglobulin Sales Market Share by Application (2015-2020)
Figure 25. Global Human Tetanus Immunoglobulin Sales Market Share by Application in 2019
Figure 26. Global Human Tetanus Immunoglobulin Revenue Market Share by Application (2015-2020)
Figure 27. Global Human Tetanus Immunoglobulin Revenue Market Share by Application in 2019
Figure 28. North America Human Tetanus Immunoglobulin Sales Growth Rate 2015-2020 (K Doses)
Figure 29. North America Human Tetanus Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Human Tetanus Immunoglobulin Sales Market Share by Country in 2019
Figure 31. North America Human Tetanus Immunoglobulin Revenue Market Share by Country in 2019
Figure 32. U.S. Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 33. U.S. Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 35. Canada Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Human Tetanus Immunoglobulin Market Share by Type in 2019
Figure 37. North America Human Tetanus Immunoglobulin Market Share by Application in 2019
Figure 38. Europe Human Tetanus Immunoglobulin Sales Growth Rate 2015-2020 (K Doses)
Figure 39. Europe Human Tetanus Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Human Tetanus Immunoglobulin Sales Market Share by Country in 2019
Figure 41. Europe Human Tetanus Immunoglobulin Revenue Market Share by Country in 2019
Figure 42. Germany Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 43. Germany Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 45. France Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 47. U.K. Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 49. Italy Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Russia Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Human Tetanus Immunoglobulin Market Share by Type in 2019
Figure 53. Europe Human Tetanus Immunoglobulin Market Share by Application in 2019
Figure 54. Asia Pacific Human Tetanus Immunoglobulin Sales Growth Rate 2015-2020 (K Doses)
Figure 55. Asia Pacific Human Tetanus Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Human Tetanus Immunoglobulin Sales Market Share by Region in 2019
Figure 57. Asia Pacific Human Tetanus Immunoglobulin Revenue Market Share by Region in 2019
Figure 58. China Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 59. China Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 61. Japan Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 63. South Korea Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 65. India Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 67. Australia Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Taiwan Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Indonesia Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Thailand Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Malaysia Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Philippines Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Vietnam Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Human Tetanus Immunoglobulin Market Share by Type in 2019
Figure 81. Asia Pacific Human Tetanus Immunoglobulin Market Share by Application in 2019
Figure 82. Latin America Human Tetanus Immunoglobulin Sales Growth Rate 2015-2020 (K Doses)
Figure 83. Latin America Human Tetanus Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Human Tetanus Immunoglobulin Sales Market Share by Country in 2019
Figure 85. Latin America Human Tetanus Immunoglobulin Revenue Market Share by Country in 2019
Figure 86. Mexico Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 87. Mexico Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Brazil Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Argentina Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Human Tetanus Immunoglobulin Market Share by Type in 2019
Figure 93. Latin America Human Tetanus Immunoglobulin Market Share by Application in 2019
Figure 94. Middle East and Africa Human Tetanus Immunoglobulin Sales Growth Rate 2015-2020 (K Doses)
Figure 95. Middle East and Africa Human Tetanus Immunoglobulin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Human Tetanus Immunoglobulin Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Human Tetanus Immunoglobulin Revenue Market Share by Country in 2019
Figure 98. Turkey Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 99. Turkey Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Saudi Arabia Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. U.A.E Human Tetanus Immunoglobulin Sales Growth Rate (2015-2020) (K Doses)
Figure 103. U.A.E Human Tetanus Immunoglobulin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Human Tetanus Immunoglobulin Market Share by Type in 2019
Figure 105. Middle East and Africa Human Tetanus Immunoglobulin Market Share by Application in 2019
Figure 106. North America Human Tetanus Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 107. North America Human Tetanus Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Human Tetanus Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 109. Europe Human Tetanus Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Human Tetanus Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 111. Asia Pacific Human Tetanus Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Human Tetanus Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 113. Latin America Human Tetanus Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Human Tetanus Immunoglobulin Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 115. Middle East and Africa Human Tetanus Immunoglobulin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
